PHARMACYTE BIOTECH, INC. Basic Shares Outstanding (Weighted Average)
PHARMACYTE BIOTECH, INC. (PMCB) reported Basic Shares Outstanding (Weighted Average) of 10.74 million shares for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-09-14
- PHARMACYTE BIOTECH, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-07-31 was 10.74M shares, a 57.98% increase year-over-year.
- PHARMACYTE BIOTECH, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-04-30 was 10.66M shares, a 55.49% increase year-over-year.
- PHARMACYTE BIOTECH, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-01-31 was 9.26M shares, a 33.09% increase year-over-year.
- PHARMACYTE BIOTECH, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-10-31 was 6.80M shares, a 11.02% decline year-over-year.
- PHARMACYTE BIOTECH, INC. weighted average number of shares outstanding, basic for fiscal 2026 was 8.38M shares, a 14.31% increase from fiscal 2025.
- PHARMACYTE BIOTECH, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 7.33M shares, a 23.50% decline from fiscal 2024.
- PHARMACYTE BIOTECH, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 9.58M shares, a 50.84% decline from fiscal 2023.
- PHARMACYTE BIOTECH, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 19.49M shares, a 25.56% increase from fiscal 2022.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | 10.74M shares 10-Q · filed 2026-09-14 | 10.70M shares derived: average of 2 quarters · filed 2026-09-14 | 10.22M shares derived: average of 3 quarters · filed 2026-09-14 | 9.36M shares derived: average of 4 quarters · filed 2026-09-14 | ||||
| 2026-04-30 | 10.66M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | 9.96M shares derived: average of 2 quarters · filed 2026-07-29 | 8.91M shares derived: average of 3 quarters · filed 2026-07-29 | 8.38M shares 10-K · filed 2026-07-29 | ||||
| 2026-01-31 | 9.26M shares 10-Q · filed 2026-03-17 | 8.03M shares derived: average of 2 quarters · filed 2026-03-17 | 7.62M shares 10-Q · filed 2026-03-17 | 7.43M shares derived: average of 4 quarters · filed 2026-09-14 | ||||
| 2025-10-31 | 6.80M shares 10-Q · filed 2025-12-18 | 6.80M shares 10-Q · filed 2025-12-18 | 6.82M shares derived: average of 3 quarters · filed 2026-09-14 | 6.85M shares derived: average of 4 quarters · filed 2026-09-14 | ||||
| 2025-07-31 | 6.80M shares 10-Q · filed 2026-09-14 | 6.83M shares derived: average of 2 quarters · filed 2026-09-14 | 6.87M shares derived: average of 3 quarters · filed 2026-09-14 | 7.06M shares derived: average of 4 quarters · filed 2026-09-14 | ||||
| 2025-04-30 | 6.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | 6.91M shares derived: average of 2 quarters · filed 2026-07-29 | 7.15M shares derived: average of 3 quarters · filed 2026-07-29 | 7.33M shares 10-K · filed 2026-07-29 | ||||
| 2025-01-31 | 6.96M shares 10-Q · filed 2026-03-17 | 7.30M shares derived: average of 2 quarters · filed 2026-03-17 | 7.49M shares 10-Q · filed 2026-03-17 | 7.70M shares derived: average of 4 quarters · filed 2026-03-17 | ||||
| 2024-10-31 | 7.64M shares 10-Q · filed 2025-12-18 | 7.75M shares 10-Q · filed 2025-12-18 | 7.95M shares derived: average of 3 quarters · filed 2025-12-18 | 8.12M shares derived: average of 4 quarters · filed 2025-12-18 | ||||
| 2024-07-31 | 7.87M shares 10-Q · filed 2025-09-15 | 8.11M shares derived: average of 2 quarters · filed 2025-09-15 | 8.27M shares derived: average of 3 quarters · filed 2025-09-15 | 8.40M shares derived: average of 4 quarters · filed 2025-09-15 | ||||
| 2024-04-30 | 8.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-11 | 8.48M shares derived: average of 2 quarters · filed 2025-08-11 | 8.57M shares derived: average of 3 quarters · filed 2025-08-11 | 9.58M shares 10-K · filed 2025-08-11 | ||||
| 2024-01-31 | 8.61M shares 10-Q · filed 2025-03-17 | 8.69M shares derived: average of 2 quarters · filed 2025-03-17 | 9.99M shares 10-Q · filed 2025-03-17 | 11.94M shares derived: average of 4 quarters · filed 2025-03-17 | ||||
| 2023-10-31 | 8.77M shares 10-Q · filed 2024-12-13 | 10.68M shares 10-Q · filed 2024-12-13 | 13.06M shares derived: average of 3 quarters · filed 2024-12-13 | 14.54M shares derived: average of 4 quarters · filed 2024-12-13 | ||||
| 2023-07-31 | 12.60M shares 10-Q · filed 2024-09-17 | 15.20M shares derived: average of 2 quarters · filed 2024-09-17 | 16.47M shares derived: average of 3 quarters · filed 2024-09-17 | 17.50M shares derived: average of 4 quarters · filed 2024-09-17 | ||||
| 2023-04-30 | 17.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-13 | 18.40M shares derived: average of 2 quarters · filed 2024-08-13 | 19.13M shares derived: average of 3 quarters · filed 2024-08-13 | 19.49M shares 10-K · filed 2024-08-13 | ||||
| 2023-01-31 | 19.00M shares 10-Q · filed 2024-03-18 | 19.79M shares derived: average of 2 quarters · filed 2024-03-18 | 20.05M shares 10-Q · filed 2024-03-18 | 20.47M shares derived: average of 4 quarters · filed 2024-03-18 | ||||
| 2022-10-31 | 20.59M shares 10-Q · filed 2023-12-15 | 20.74M shares 10-Q · filed 2023-12-15 | 20.96M shares derived: average of 3 quarters · filed 2023-12-15 | 21.14M shares derived: average of 4 quarters · filed 2023-12-15 | ||||
| 2022-07-31 | 20.83M shares 10-Q · filed 2023-09-18 | 21.15M shares derived: average of 2 quarters · filed 2023-09-18 | 21.32M shares derived: average of 3 quarters · filed 2023-09-18 | 20.33M shares derived: average of 4 quarters · filed 2023-09-18 | ||||
| 2022-04-30 | 21.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-31 | 21.57M shares derived: average of 2 quarters · filed 2023-07-31 | 20.17M shares derived: average of 3 quarters · filed 2023-07-31 | 15.52M shares 10-K · filed 2023-07-31 | ||||
| 2022-01-31 | 21.67M shares 10-Q · filed 2023-03-16 | 19.51M shares derived: average of 2 quarters · filed 2023-03-16 | 13.54M shares 10-Q · filed 2023-03-16 | 10.55M shares derived: average of 4 quarters · filed 2023-03-16 | ||||
| 2021-10-31 | 17.36M shares 10-Q · filed 2022-12-14 | 9.47M shares 10-Q · filed 2022-12-14 | 6.84M shares derived: average of 3 quarters · filed 2022-12-14 | 5.52M shares derived: average of 4 quarters · filed 2022-12-14 | ||||
| 2021-07-31 | 1.59M shares 10-Q · filed 2022-09-14 | 1.58M shares derived: average of 2 quarters · filed 2022-09-14 | 1.58M shares derived: average of 3 quarters · filed 2022-09-14 | 1.57M shares derived: average of 4 quarters · filed 2022-09-14 | ||||
| 2021-04-30 | 1.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-28 | 1.57M shares derived: average of 2 quarters · filed 2022-07-28 | 1.56M shares derived: average of 3 quarters · filed 2022-07-28 | 1.45M shares 10-K · filed 2022-07-28 | ||||
| 2021-01-31 | 1.56M shares 10-Q · filed 2022-03-15 | 2.34B shares 10-Q · filed 2021-03-12 | 1.55M shares derived: average of 2 quarters · filed 2022-03-15 | 1.41M shares 10-Q · filed 2022-03-15 | 2.11B shares 10-Q · filed 2021-03-12 | -961.42M shares derived: average of 4 quarters · filed 2022-03-15 | ||
| 2020-10-31 | 1.54M shares 10-Q · filed 2021-12-14 | 2.31B shares 10-Q · filed 2020-12-11 | 1.33M shares 10-Q · filed 2021-12-14 | 1.99B shares 10-Q · filed 2020-12-11 | -1.28B shares derived: average of 3 quarters · filed 2021-12-14 | -617.93M shares derived: average of 4 quarters · filed 2021-12-14 | ||
| 2020-07-31 | 1.12M shares 10-Q · filed 2021-09-14 | 1.68B shares 10-Q · filed 2020-09-11 | -1.92B shares derived: average of 2 quarters · filed 2021-09-14 | -824.42M shares derived: average of 3 quarters · filed 2021-09-14 | -287.05M shares derived: average of 4 quarters · filed 2021-09-14 | |||
| 2020-04-30 | -3.85B shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-10 | -1.24B shares derived: average of 2 quarters · filed 2021-08-10 | -383.10M shares derived: average of 3 quarters · filed 2021-08-10 | 903.81K shares 10-K · filed 2021-08-10 | 1.36B shares 10-K · filed 2020-08-13 | |||
| 2020-01-31 | 1.38B shares 10-Q · filed 2021-03-12 | 1.33B shares 10-Q · filed 2020-03-13 | 1.35B shares derived: average of 2 quarters · filed 2021-03-12 | 1.28B shares 10-Q · filed 2021-03-12 | 1.26B shares derived: average of 4 quarters · filed 2021-03-12 | |||
| 2019-10-31 | 1.33B shares 10-Q · filed 2020-12-11 | 1.27B shares 10-Q · filed 2020-12-11 | 1.23B shares derived: average of 3 quarters · filed 2020-12-11 | 1.20B shares derived: average of 4 quarters · filed 2020-12-11 | ||||
| 2019-07-31 | 1.21B shares 10-Q · filed 2020-09-11 | 1.18B shares derived: average of 2 quarters · filed 2020-09-11 | 1.16B shares derived: average of 3 quarters · filed 2020-09-11 | 1.14B shares derived: average of 4 quarters · filed 2020-09-11 | ||||
| 2019-04-30 | 1.15B shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-13 | 1.14B shares derived: average of 2 quarters · filed 2020-08-13 | 1.12B shares derived: average of 3 quarters · filed 2020-08-13 | 1.10B shares 10-K · filed 2020-08-13 | ||||
| 2019-01-31 | 1.13B shares 10-Q · filed 2020-03-13 | 1.10B shares derived: average of 2 quarters · filed 2020-03-13 | 1.08B shares 10-Q · filed 2020-03-13 | 1.06B shares derived: average of 4 quarters · filed 2020-03-13 | ||||
| 2018-10-31 | 1.08B shares 10-Q · filed 2019-12-23 | 1.06B shares 10-Q · filed 2019-12-23 | 1.04B shares derived: average of 3 quarters · filed 2019-12-23 | 1.03B shares derived: average of 4 quarters · filed 2019-12-23 | ||||
| 2018-07-31 | 1.05B shares 10-Q · filed 2019-09-13 | 1.02B shares derived: average of 2 quarters · filed 2019-09-13 | 1.01B shares derived: average of 3 quarters · filed 2019-09-13 | 998.87M shares derived: average of 4 quarters · filed 2019-09-13 | ||||
| 2018-04-30 | 999.97M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-13 | 987.91M shares derived: average of 2 quarters · filed 2019-08-13 | 983.00M shares derived: average of 3 quarters · filed 2019-08-13 | 968.64M shares 10-K · filed 2019-08-13 | ||||
| 2018-01-31 | 975.85M shares 10-Q · filed 2019-03-14 | 974.51M shares derived: average of 2 quarters · filed 2019-03-14 | 958.20M shares 10-Q · filed 2019-03-14 | 939.80M shares derived: average of 4 quarters · filed 2019-03-14 | ||||
| 2017-10-31 | 973.17M shares 10-Q · filed 2018-12-14 | 949.37M shares 10-Q · filed 2018-12-14 | 927.79M shares derived: average of 3 quarters · filed 2018-12-14 | 910.72M shares derived: average of 4 quarters · filed 2018-12-14 | ||||
| 2017-07-31 | 925.58M shares 10-Q · filed 2018-09-12 | 905.10M shares derived: average of 2 quarters · filed 2018-09-12 | 889.91M shares derived: average of 3 quarters · filed 2018-09-12 | 879.66M shares derived: average of 4 quarters · filed 2018-09-12 | ||||
| 2017-04-30 | 884.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-20 | 872.08M shares derived: average of 2 quarters · filed 2018-07-20 | 864.35M shares derived: average of 3 quarters · filed 2018-07-20 | 845.31M shares 10-K · filed 2018-07-20 | ||||
| 2017-01-31 | 859.53M shares 10-Q · filed 2018-03-19 | 854.22M shares derived: average of 2 quarters · filed 2018-03-19 | 832.20M shares 10-Q · filed 2018-03-19 | 816.58M shares derived: average of 4 quarters · filed 2018-03-19 | ||||
| 2016-10-31 | 848.91M shares 10-Q · filed 2017-12-14 | 818.54M shares 10-Q · filed 2017-12-14 | 802.26M shares derived: average of 3 quarters · filed 2017-12-14 | 790.85M shares derived: average of 4 quarters · filed 2017-12-14 | ||||
| 2016-07-31 | 788.17M shares 10-Q · filed 2017-09-13 | 778.94M shares derived: average of 2 quarters · filed 2017-09-13 | 771.50M shares derived: average of 3 quarters · filed 2017-09-13 | 764.97M shares derived: average of 4 quarters · filed 2017-09-13 | ||||
| 2016-04-30 | 769.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-27 | 763.17M shares derived: average of 2 quarters · filed 2017-07-27 | 757.23M shares derived: average of 3 quarters · filed 2017-07-27 | 752.40M shares 10-K · filed 2017-07-27 | ||||
| 2016-01-31 | 756.64M shares 10-Q · filed 2017-03-13 | 751.00M shares derived: average of 2 quarters · filed 2017-03-13 | 746.64M shares 10-Q · filed 2017-03-13 | 737.33M shares derived: average of 4 quarters · filed 2017-03-13 | ||||
| 2015-10-31 | 745.36M shares 10-Q · filed 2016-12-02 | 741.64M shares 10-Q · filed 2016-12-02 | 730.89M shares derived: average of 3 quarters · filed 2016-12-02 | 722.20M shares derived: average of 4 quarters · filed 2016-12-02 | ||||
| 2015-07-31 | 737.92M shares 10-Q · filed 2016-09-06 | 723.65M shares derived: average of 2 quarters · filed 2016-09-06 | 714.48M shares derived: average of 3 quarters · filed 2016-09-06 | 711.70M shares derived: average of 4 quarters · filed 2016-09-06 | ||||
| 2015-04-30 | 709.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | 702.77M shares derived: average of 2 quarters · filed 2016-07-29 | 702.96M shares derived: average of 3 quarters · filed 2016-07-29 | 704.33M shares 10-K · filed 2016-07-29 | ||||
| 2015-01-31 | 696.15M shares 10-Q · filed 2015-03-13 | 699.74M shares derived: average of 2 quarters · filed 2015-03-13 | 702.64M shares 10-Q · filed 2015-03-13 | 692.37M shares derived: average of 4 quarters · filed 2016-07-29 | ||||
| 2014-10-31 | 703.33M shares 10-Q · filed 2014-12-15 | 702.63M shares 10-Q · filed 2014-12-15 | 691.11M shares derived: average of 3 quarters · filed 2016-07-29 | 668.31M shares derived: average of 4 quarters · filed 2016-07-29 | ||||
| 2014-07-31 | 701.93M shares 10-Q · filed 2014-09-15 | 685.00M shares derived: average of 2 quarters · filed 2016-07-29 | 656.64M shares derived: average of 3 quarters · filed 2016-07-29 | 627.79M shares derived: average of 4 quarters · filed 2016-07-29 | ||||
| 2014-04-30 | 668.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | 634.00M shares derived: average of 2 quarters · filed 2016-07-29 | 603.07M shares derived: average of 3 quarters · filed 2016-07-29 | 583.22M shares 10-K · filed 2016-07-29 | ||||
| 2014-01-31 | 599.92M shares 10-Q · filed 2015-03-13 | 570.58M shares derived: average of 2 quarters · filed 2015-03-13 | 554.94M shares 10-Q · filed 2015-03-13 | 531.96M shares derived: average of 4 quarters · filed 2016-01-19 | ||||
| 2013-10-31 | 541.23M shares 10-Q · filed 2014-12-15 | 533.31M shares 10-Q · filed 2014-12-15 | 509.30M shares derived: average of 3 quarters · filed 2016-01-19 | 493.14M shares derived: average of 4 quarters · filed 2016-01-19 | ||||
| 2013-07-31 | 521.87M shares 10-Q · filed 2014-09-15 | 493.33M shares derived: average of 2 quarters · filed 2016-01-19 | 477.12M shares derived: average of 3 quarters · filed 2016-01-19 | 465.20M shares derived: average of 4 quarters · filed 2016-01-19 | ||||
| 2013-04-30 | 464.79M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-01-19 | 454.74M shares derived: average of 2 quarters · filed 2016-01-19 | 446.31M shares derived: average of 3 quarters · filed 2016-01-19 | 440.95M shares 10-K/A · filed 2016-01-19 | ||||
| 2013-01-31 | 444.68M shares 10-Q · filed 2014-03-17 | 437.07M shares derived: average of 2 quarters · filed 2014-03-17 | 433.01M shares 10-Q · filed 2014-03-17 | 419.29M shares derived: average of 4 quarters · filed 2014-03-17 | ||||
| 2012-10-31 | 429.46M shares 10-Q · filed 2013-12-16 | 424.51M shares 10-Q · filed 2013-12-16 | 410.83M shares derived: average of 3 quarters · filed 2013-12-16 | 401.45M shares derived: average of 4 quarters · filed 2013-12-16 | ||||
| 2012-07-31 | 419.57M shares 10-Q · filed 2013-09-16 | 401.51M shares derived: average of 2 quarters · filed 2013-09-16 | 392.12M shares derived: average of 3 quarters · filed 2013-09-16 | 387.61M shares derived: average of 4 quarters · filed 2013-09-16 | ||||
| 2012-04-30 | 383.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-29 | 378.39M shares derived: average of 2 quarters · filed 2013-07-29 | 376.96M shares derived: average of 3 quarters · filed 2013-07-29 | 374.76M shares 10-K · filed 2013-07-29 | ||||
| 2012-01-31 | 373.34M shares 10-Q · filed 2013-03-26 | 373.71M shares derived: average of 2 quarters · filed 2013-03-26 | 371.87M shares 10-Q · filed 2013-03-26 | 367.73M shares derived: average of 4 quarters · filed 2013-03-26 | ||||
| 2011-10-31 | 374.09M shares 10-Q · filed 2012-12-26 | 370.93M shares 10-Q · filed 2012-12-26 | 365.87M shares derived: average of 3 quarters · filed 2012-12-26 | 361.50M shares derived: average of 4 quarters · filed 2012-12-26 | ||||
| 2011-07-31 | 367.29M shares 10-Q · filed 2012-09-19 | 361.75M shares derived: average of 2 quarters · filed 2012-09-19 | 357.30M shares derived: average of 3 quarters · filed 2012-09-19 | 355.07M shares derived: average of 4 quarters · filed 2012-09-19 | ||||
| 2011-04-30 | 356.21M shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-14 | 352.30M shares derived: average of 2 quarters · filed 2012-08-14 | 351.00M shares derived: average of 3 quarters · filed 2012-08-14 | 350.34M shares 10-K · filed 2012-08-14 | ||||
| 2011-01-31 | 348.39M shares 10-Q · filed 2012-03-21 | 348.39M shares derived: average of 2 quarters · filed 2012-03-21 | 348.39M shares 10-Q · filed 2012-03-21 | |||||
| 2010-10-31 | 348.39M shares 10-Q · filed 2011-12-15 | 348.39M shares 10-Q · filed 2011-12-15 | ||||||
| 2010-07-31 | 348.39M shares 10-Q/A · filed 2011-09-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |